Kinyanjui SM

23 results

Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.Kimingi HW, Kinyua AW, Achieng NA, Wambui KM, Mwangi S, Nguti R, Kivisi CA, Jensen ATR, Bejon P, Kapulu MC, Abdi AI, Kinyanjui SM, CHMI-SIKA Study Team
Front Immunol, (2022). 13:894770

The burden of neurological impairments and disability in older children measured in disability-adjusted life-years in rural Kenya.Abuga JA, Kariuki SM, Abubakar A, Kinyanjui SM, van Hensbroek MB, Newton CR
PLOS Glob Public Health, (2022). 2:e0000151

Neurological impairment and disability in children in rural Kenya.Abuga JA, Kariuki SM, Abubakar A, Nyundo C, Kinyanjui SM, Van Hensbroek MB, Newton CR
Dev Med Child Neurol, (2022). 64:347-356

Barriers to access and utilization of healthcare by children with neurological impairments and disability in low-and middle-income countries: a systematic review.Mwangi LW, Abuga JA, Cottrell E, Kariuki SM, Kinyanjui SM, Newton CR
Wellcome Open Res, (2021). 6:61

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.Githinji G, de Laurent ZR, Mohammed KS, Omuoyo DO, Macharia PM, Morobe JM, Otieno E, Kinyanjui SM, Agweyu A, Maitha E, Kitole B, Suleiman T, Mwakinangu M, Nyambu J, Otieno J, Salim B, Kasera K, Kiiru J, Aman R, Barasa E, Warimwe G, Bejon P, Tsofa B, Ochola-Oyier LI, Nokes DJ, Agoti CN
Nat Commun, (2021). 12:4809

Premature Mortality, Risk Factors, and Causes of Death Following Childhood-Onset Neurological Impairments: A Systematic Review.Abuga JA, Kariuki SM, Kinyanjui SM, Boele van Hensbroek M, Newton CR
Front Neurol, (2021). 12:627824

Enhancing fieldworkers' performance management support in health research: an exploratory study on the views of field managers and fieldworkers from major research centres in Africa.Kombe FK, Marsh V, Molyneux S, Kamuya DM, Ikamba D, Kinyanjui SM
BMJ Open, (2019). 9:e028453

Premature mortality in children aged 6-9 years with neurological impairments in rural Kenya: a cohort study.Abuga JA, Kariuki SM, Kinyanjui SM, Boele Van Hensbroek M, Newton CR
Lancet Glob Health, (2019). 7:e1728-e1735

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.Kamuyu G, Tuju J, Kimathi R, Mwai K, Mburu J, Kibinge N, Chong Kwan M, Hawkings S, Yaa R, Chepsat E, Njunge JM, Chege T, Guleid F, Rosenkranz M, Kariuki CK, Frank R, Kinyanjui SM, Murungi LM, Bejon P, Farnert A, Tetteh KKA, Beeson JG, Conway DJ, Marsh K, Rayner JC, Osier FHA
Front Immunol, (2018). 9:2866

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, Marsh K, Osier FH
Vaccine, (2013). 31:3936-42

Strengthening the informed consent process in international health research through community engagement: The KEMRI-Wellcome Trust Research Programme Experience.Boga M, Davies A, Kamuya D, Kinyanjui SM, Kivaya E, Kombe F, Lang T, Marsh V, Mbete B, Mlamba A, Molyneux S, Mulupi S, Mwalukore S
PLoS Med, (2011). 8:e1001089

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study.Muema DK, Ndungu FM, Kinyanjui SM, Berkley JA
Malar J, (2011). 10:55

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui SM, Bejon P, Osier FH, Bull PC, Marsh K
Malar J, (2009). 8:242

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, Musyoki JN, Bull PC, Marsh K
Infect Immun, (2009). 77:1917-23

Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children.Mackintosh CL, Mwangi T, Kinyanjui SM, Mosobo M, Pinches R, Williams TN, Newbold CI, Marsh K
Int J Parasitol, (2008). 38:1445-54

Evidence for over-dispersion in the distribution of clinical malaria episodes in children.Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K
PLoS One, (2008). 3:e2196

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.Kinyanjui SM, Conway DJ, Lanar DE, Marsh K
Malar J, (2007). 6:82

Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.Bull PC, Pain A, Ndungu FM, Kinyanjui SM, Roberts DJ, Newbold CI, Marsh K
J Infect Dis, (2005). 192:1119-26

Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K
J Infect Dis, (2004). 190:1527-33

The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K
J Immunol Methods, (2004). 288:9-18